Loading…

Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers

Abstract Background Approximately 30 million people worldwide consume new psychoactive substances (NPS), creating a serious public health issue due to their toxicity and potency. Drug-induced liver injury is the leading cause of liver disease, responsible for 4% of global deaths each year. Content A...

Full description

Saved in:
Bibliographic Details
Published in:Clinical chemistry (Baltimore, Md.) Md.), 2024-04, Vol.70 (4), p.597-628
Main Authors: Balloni, Aurora, Tini, Anastasio, Prospero, Emilia, Busardò, Francesco Paolo, Huestis, Marilyn Ann, Lo Faro, Alfredo Fabrizio
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c288t-18f6ce7cd42124b8cb4bcbf0ad07278b4e449cdf1330d45881d55ce9bda8433
container_end_page 628
container_issue 4
container_start_page 597
container_title Clinical chemistry (Baltimore, Md.)
container_volume 70
creator Balloni, Aurora
Tini, Anastasio
Prospero, Emilia
Busardò, Francesco Paolo
Huestis, Marilyn Ann
Lo Faro, Alfredo Fabrizio
description Abstract Background Approximately 30 million people worldwide consume new psychoactive substances (NPS), creating a serious public health issue due to their toxicity and potency. Drug-induced liver injury is the leading cause of liver disease, responsible for 4% of global deaths each year. Content A systematic literature search revealed 64 case reports, in vitro and in vivo studies on NPS hepatotoxicity. Maximum elevated concentrations of aspartate aminotransferase (136 to 15 632 U/L), alanine transaminase (121.5 to 9162 U/L), total bilirubin (0.7 to 702 mg/dL; 0.04 to 39.03 mmol/L), direct (0.2–15.1 mg/dL; 0.01–0.84 mmol/L) and indirect (5.3 mg/dL; 0.29 mmol/L) bilirubin, alkaline phosphatase (79–260 U/L), and gamma-glutamyltransferase (260 U/L) were observed as biochemical markers of liver damage, with acute and fulminant liver failure the major toxic effects described in the NPS case reports. In vitro laboratory studies and subsequent in vivo NPS exposure studies on rats and mice provide data on potential mechanisms of toxicity. Oxidative stress, plasma membrane stability, and cellular energy changes led to apoptosis and cell death. Experimental studies of human liver microsome incubation with synthetic NPS, with and without specific cytochrome P450 inhibitors, highlighted specific enzyme inhibitions and potential drug–drug interactions leading to hepatotoxicity. Summary Mild to severe hepatotoxic effects following synthetic NPS exposure were described in case reports. In diagnosing the etiology of liver damage, synthetic NPS exposure should be considered as part of the differential diagnosis. Identification of NPS toxicity is important for educating patients on the dangers of NPS consumption and to suggest promising treatments for observed hepatotoxicity.
doi_str_mv 10.1093/clinchem/hvad210
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2934269133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/clinchem/hvad210</oup_id><sourcerecordid>2934269133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-18f6ce7cd42124b8cb4bcbf0ad07278b4e449cdf1330d45881d55ce9bda8433</originalsourceid><addsrcrecordid>eNqFkM9LwzAUx4MoOn_cPUmOgtQlTbqm3sZQN5gozHtJX15ZtW1qksr231vZ5tXT48Hn8z18CLnm7J6zTIyhrlpYYzNef2sTc3ZERjwRLFLJhB-TEWMsizIu0zNy7v3H8MpUTU7JmVAyTrNEjMjn46azvndIg6WrbRvWGCqgb34La6shVN9IV33hg24B_QOd0jcbsA2VrulM9x5paR1dtOBQezR03je6pXPsdLDBbiqowpa-aPeJzl-Sk1LXHq_294Ksnh7fZ_No-fq8mE2XEcRKhYircgKYgpExj2WhoJAFFCXThqVxqgqJUmZgSi4EMzJRipskAcwKo5UU4oLc7lY7Z7969CFvKg9Y17pF2_s8zoSMJ9lgDyjboeCs9w7LvHNVo9025yz_DZwfAuf7wINys1_viwbNn3AoOgB3O8D23f9zP_B5ix0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2934269133</pqid></control><display><type>article</type><title>Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers</title><source>Oxford Journals Online</source><creator>Balloni, Aurora ; Tini, Anastasio ; Prospero, Emilia ; Busardò, Francesco Paolo ; Huestis, Marilyn Ann ; Lo Faro, Alfredo Fabrizio</creator><creatorcontrib>Balloni, Aurora ; Tini, Anastasio ; Prospero, Emilia ; Busardò, Francesco Paolo ; Huestis, Marilyn Ann ; Lo Faro, Alfredo Fabrizio</creatorcontrib><description>Abstract Background Approximately 30 million people worldwide consume new psychoactive substances (NPS), creating a serious public health issue due to their toxicity and potency. Drug-induced liver injury is the leading cause of liver disease, responsible for 4% of global deaths each year. Content A systematic literature search revealed 64 case reports, in vitro and in vivo studies on NPS hepatotoxicity. Maximum elevated concentrations of aspartate aminotransferase (136 to 15 632 U/L), alanine transaminase (121.5 to 9162 U/L), total bilirubin (0.7 to 702 mg/dL; 0.04 to 39.03 mmol/L), direct (0.2–15.1 mg/dL; 0.01–0.84 mmol/L) and indirect (5.3 mg/dL; 0.29 mmol/L) bilirubin, alkaline phosphatase (79–260 U/L), and gamma-glutamyltransferase (260 U/L) were observed as biochemical markers of liver damage, with acute and fulminant liver failure the major toxic effects described in the NPS case reports. In vitro laboratory studies and subsequent in vivo NPS exposure studies on rats and mice provide data on potential mechanisms of toxicity. Oxidative stress, plasma membrane stability, and cellular energy changes led to apoptosis and cell death. Experimental studies of human liver microsome incubation with synthetic NPS, with and without specific cytochrome P450 inhibitors, highlighted specific enzyme inhibitions and potential drug–drug interactions leading to hepatotoxicity. Summary Mild to severe hepatotoxic effects following synthetic NPS exposure were described in case reports. In diagnosing the etiology of liver damage, synthetic NPS exposure should be considered as part of the differential diagnosis. Identification of NPS toxicity is important for educating patients on the dangers of NPS consumption and to suggest promising treatments for observed hepatotoxicity.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1093/clinchem/hvad210</identifier><identifier>PMID: 38427953</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Clinical chemistry (Baltimore, Md.), 2024-04, Vol.70 (4), p.597-628</ispartof><rights>Association for Diagnostics &amp; Laboratory Medicine 2024. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2024</rights><rights>Association for Diagnostics &amp; Laboratory Medicine 2024. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c288t-18f6ce7cd42124b8cb4bcbf0ad07278b4e449cdf1330d45881d55ce9bda8433</cites><orcidid>0000-0003-2137-4645</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38427953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balloni, Aurora</creatorcontrib><creatorcontrib>Tini, Anastasio</creatorcontrib><creatorcontrib>Prospero, Emilia</creatorcontrib><creatorcontrib>Busardò, Francesco Paolo</creatorcontrib><creatorcontrib>Huestis, Marilyn Ann</creatorcontrib><creatorcontrib>Lo Faro, Alfredo Fabrizio</creatorcontrib><title>Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers</title><title>Clinical chemistry (Baltimore, Md.)</title><addtitle>Clin Chem</addtitle><description>Abstract Background Approximately 30 million people worldwide consume new psychoactive substances (NPS), creating a serious public health issue due to their toxicity and potency. Drug-induced liver injury is the leading cause of liver disease, responsible for 4% of global deaths each year. Content A systematic literature search revealed 64 case reports, in vitro and in vivo studies on NPS hepatotoxicity. Maximum elevated concentrations of aspartate aminotransferase (136 to 15 632 U/L), alanine transaminase (121.5 to 9162 U/L), total bilirubin (0.7 to 702 mg/dL; 0.04 to 39.03 mmol/L), direct (0.2–15.1 mg/dL; 0.01–0.84 mmol/L) and indirect (5.3 mg/dL; 0.29 mmol/L) bilirubin, alkaline phosphatase (79–260 U/L), and gamma-glutamyltransferase (260 U/L) were observed as biochemical markers of liver damage, with acute and fulminant liver failure the major toxic effects described in the NPS case reports. In vitro laboratory studies and subsequent in vivo NPS exposure studies on rats and mice provide data on potential mechanisms of toxicity. Oxidative stress, plasma membrane stability, and cellular energy changes led to apoptosis and cell death. Experimental studies of human liver microsome incubation with synthetic NPS, with and without specific cytochrome P450 inhibitors, highlighted specific enzyme inhibitions and potential drug–drug interactions leading to hepatotoxicity. Summary Mild to severe hepatotoxic effects following synthetic NPS exposure were described in case reports. In diagnosing the etiology of liver damage, synthetic NPS exposure should be considered as part of the differential diagnosis. Identification of NPS toxicity is important for educating patients on the dangers of NPS consumption and to suggest promising treatments for observed hepatotoxicity.</description><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkM9LwzAUx4MoOn_cPUmOgtQlTbqm3sZQN5gozHtJX15ZtW1qksr231vZ5tXT48Hn8z18CLnm7J6zTIyhrlpYYzNef2sTc3ZERjwRLFLJhB-TEWMsizIu0zNy7v3H8MpUTU7JmVAyTrNEjMjn46azvndIg6WrbRvWGCqgb34La6shVN9IV33hg24B_QOd0jcbsA2VrulM9x5paR1dtOBQezR03je6pXPsdLDBbiqowpa-aPeJzl-Sk1LXHq_294Ksnh7fZ_No-fq8mE2XEcRKhYircgKYgpExj2WhoJAFFCXThqVxqgqJUmZgSi4EMzJRipskAcwKo5UU4oLc7lY7Z7969CFvKg9Y17pF2_s8zoSMJ9lgDyjboeCs9w7LvHNVo9025yz_DZwfAuf7wINys1_viwbNn3AoOgB3O8D23f9zP_B5ix0</recordid><startdate>20240403</startdate><enddate>20240403</enddate><creator>Balloni, Aurora</creator><creator>Tini, Anastasio</creator><creator>Prospero, Emilia</creator><creator>Busardò, Francesco Paolo</creator><creator>Huestis, Marilyn Ann</creator><creator>Lo Faro, Alfredo Fabrizio</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2137-4645</orcidid></search><sort><creationdate>20240403</creationdate><title>Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers</title><author>Balloni, Aurora ; Tini, Anastasio ; Prospero, Emilia ; Busardò, Francesco Paolo ; Huestis, Marilyn Ann ; Lo Faro, Alfredo Fabrizio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-18f6ce7cd42124b8cb4bcbf0ad07278b4e449cdf1330d45881d55ce9bda8433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balloni, Aurora</creatorcontrib><creatorcontrib>Tini, Anastasio</creatorcontrib><creatorcontrib>Prospero, Emilia</creatorcontrib><creatorcontrib>Busardò, Francesco Paolo</creatorcontrib><creatorcontrib>Huestis, Marilyn Ann</creatorcontrib><creatorcontrib>Lo Faro, Alfredo Fabrizio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balloni, Aurora</au><au>Tini, Anastasio</au><au>Prospero, Emilia</au><au>Busardò, Francesco Paolo</au><au>Huestis, Marilyn Ann</au><au>Lo Faro, Alfredo Fabrizio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><addtitle>Clin Chem</addtitle><date>2024-04-03</date><risdate>2024</risdate><volume>70</volume><issue>4</issue><spage>597</spage><epage>628</epage><pages>597-628</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>Abstract Background Approximately 30 million people worldwide consume new psychoactive substances (NPS), creating a serious public health issue due to their toxicity and potency. Drug-induced liver injury is the leading cause of liver disease, responsible for 4% of global deaths each year. Content A systematic literature search revealed 64 case reports, in vitro and in vivo studies on NPS hepatotoxicity. Maximum elevated concentrations of aspartate aminotransferase (136 to 15 632 U/L), alanine transaminase (121.5 to 9162 U/L), total bilirubin (0.7 to 702 mg/dL; 0.04 to 39.03 mmol/L), direct (0.2–15.1 mg/dL; 0.01–0.84 mmol/L) and indirect (5.3 mg/dL; 0.29 mmol/L) bilirubin, alkaline phosphatase (79–260 U/L), and gamma-glutamyltransferase (260 U/L) were observed as biochemical markers of liver damage, with acute and fulminant liver failure the major toxic effects described in the NPS case reports. In vitro laboratory studies and subsequent in vivo NPS exposure studies on rats and mice provide data on potential mechanisms of toxicity. Oxidative stress, plasma membrane stability, and cellular energy changes led to apoptosis and cell death. Experimental studies of human liver microsome incubation with synthetic NPS, with and without specific cytochrome P450 inhibitors, highlighted specific enzyme inhibitions and potential drug–drug interactions leading to hepatotoxicity. Summary Mild to severe hepatotoxic effects following synthetic NPS exposure were described in case reports. In diagnosing the etiology of liver damage, synthetic NPS exposure should be considered as part of the differential diagnosis. Identification of NPS toxicity is important for educating patients on the dangers of NPS consumption and to suggest promising treatments for observed hepatotoxicity.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>38427953</pmid><doi>10.1093/clinchem/hvad210</doi><tpages>32</tpages><orcidid>https://orcid.org/0000-0003-2137-4645</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0009-9147
ispartof Clinical chemistry (Baltimore, Md.), 2024-04, Vol.70 (4), p.597-628
issn 0009-9147
1530-8561
language eng
recordid cdi_proquest_miscellaneous_2934269133
source Oxford Journals Online
title Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exposure%20to%20Synthetic%20Psychoactive%20Substances:%20A%20Potential%20Cause%20for%20Increased%20Human%20Hepatotoxicity%20Markers&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Balloni,%20Aurora&rft.date=2024-04-03&rft.volume=70&rft.issue=4&rft.spage=597&rft.epage=628&rft.pages=597-628&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1093/clinchem/hvad210&rft_dat=%3Cproquest_cross%3E2934269133%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c288t-18f6ce7cd42124b8cb4bcbf0ad07278b4e449cdf1330d45881d55ce9bda8433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2934269133&rft_id=info:pmid/38427953&rft_oup_id=10.1093/clinchem/hvad210&rfr_iscdi=true